Identifying genes that are essential for mouse embryonic Background: development and survival through term is a powerful and unbiased way to discover possible genetic determinants of human developmental disorders. Characterising the changes in mouse embryos that result from ablation of lethal genes is a necessary first step towards uncovering their role in normal embryonic development and establishing any correlates amongst human congenital abnormalities.
Introduction
Animal models have long been used as experimental surrogates for investigating the role of individual genes in human development and disease. The remarkable degree of conservation in gene sequence and role that we now know exists across species confirms the validity of this approach and genetic manipulation in the mouse provides a commonly used way to explore gene function. The most ambitious example of this is the attempt coordinated by the International Mouse Phenotyping Consortium (IMPC) to generate a catalogue of gene function, using a systematic approach to phenotyping of individual gene knockouts (KO) that cover the entire mouse genome. In generating KO lines from about one quarter of the total mouse genome so far, these studies have revealed that around one third of all mammalian genes are essential for life [1] [2] [3] , their removal resulting in embryonic or perinatal lethality. The study of such mutant lines provides a unique opportunity to gain a comprehensive overview of the genetic components regulating normal embryo development and, by inference, the identity of genes whose mutation may cause congenital abnormalities or developmental disease.
Deciphering the Mechanisms of Developmental Disorders (DMDD) is a five year, UK-based programme funded by the Wellcome Trust with the goal of studying 240 embryonic lethal KO lines 3 . By applying systematic phenotyping methods for homozygous mutant embryos with parallel efforts to identify placental abnormalities and changes in early embryo transcriptome profiles, DMDD offers a foundation for identifying novel genes important for developmental or clinical studies. Here we summarise results to date from detailed examination of homozygous mutant embryos at E14.5 for structural abnormalities.
Materials and methods

Embryos
All embryos were produced by the Wellcome Trust Sanger Institute (https://www.sanger.ac.uk/mouseportal/) as part of the DMDD project 3 . Gene knockout lines produced as part of a systematic programme coordinated by the International Mouse Phenotyping Consortium (http://www.mousephenotype.org) were designated lethal if no homozygous mutants were present amongst a minimum of 28 pups at P14 and sub-viable if their proportion fell below 13% of total offspring 2 . Embryos were harvested from one or more litters at E14.5, fixed in Bouin's fixative for 24 hours and stored at 4°C in phosphate buffered saline.
Generation of digital volume data
Embryos were initially scored for gross abnormalities under a dissection microscope before preparation for 3D imaging. Briefly, embryos were dehydrated in methanol (10% steps until 90%, followed by 95% and 100%; at least 2 hours each) and embedded in methacrylate resin (JB-4, PolySciences) containing eosin B and acridine orange, as previously described [4] [5] [6] . Within each resin block, the embryo was oriented to ensure transverse sectioning along its longitudinal axis. Resin blocks were allowed to polymerise overnight at room temperature, baked at 90°C for 24-48 hours and then subjected to digital volume data generation using highresolution episcopic microscopy (HREM) 7 . HREM data was downsized as appropriate to provide an isotropic voxel size of between 2.5-3 µm, depending on original section thickness.
Data processing and annotation 12 bit raw greyscale image data was adjusted to optimise tissue visualisation using Photoshop 6 (Adobe) . Data visualisation and analysis was performed using software packages Amira 5 (ThermoFisher Scientific) and Osirix, versions [6] [7] [8] . Virtual 2D sections were used for phenotype scoring, essentially as described in a recently published protocol 8 , each phenotype call being assigned to a 3D point in each embryo image data stack. Abnormalities were classified by using the Mammalian Phenotype (MP) ontology 9 using the most specific MP term that described each defect. 3D volume rendered models were employed for developmental staging from external morphology.
Data analysis
In order to facilitate summarising of detailed phenotype annotation data, two subsets of the MP terms closer to the root of the ontology were chosen to provide structured "high" and "intermediate" level overviews of DMDD phenotype data. These MP ontology slims are shown in Table 4 and Table 5 . The MP terms assigned during annotation of the embryos were summarised into the categories defined by the DMDD slims using the Map2Slim algorithm (https://metacpan.org/pod/distribution/go-perl/scripts/map2slim). All the terms of the DMDD slims that map to terms used to annotate embryo phenotypes are listed in Supplementary Table 1. MP annotation terms used to describe the phenotypes of each embryo of a line were normalised to remove duplicate terms, and the terms for each embryo were mapped onto the ontology slims. For each line, a set of the unique slim terms observed for the line was generated and lists were produced of all the embryos from the line falling into each of these high or intermediate level categories. This enabled calculation of a penetrance score for each of the broad slim terms, calculated as a ratio of the number of embryos listed for the slim category to the number of homozygous mutant embryos analysed for the line.
To obtain a global view of the phenotypes detected, the frequency of lines showing each of the broad category slim terms were counted across all the lines analysed. In addition, the incidence of embryos scored for every phenotype category described by the slim terms, and the total number of embryos analysed in lines exhibiting each individual phenotype category was counted.
The total number of lines for each slim term that had a penetrance score between 0-0.24, 0.25-0.49, 0.50-0.74 and 0.75-1.00 was recorded. We calculated the cumulative penetrance score for each slim term as the overall sum of the penetrance scores of every line showing this broad category phenotype. In addition, for each of the penetrance intervals listed above, the sum of the penetrance scores was calculated for the lines falling into these categories.
All plots showing analysis of the data were produced using the R software package, version 3.2. 1 (2015-06-18 ) (The R Foundation for Statistical Computing).
Use of animals
The care and use of all mice in this study were in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act of 1986 (PPL 80/2485) and were approved by the Wellcome Trust Sanger Institute's Animal Welfare and Ethical Review Body.
Results
Size of the study
The data for this study comprises 220 homozygous mutant E14.5 embryos analysed by the DMDD programme. All data is presented in Dataset 1 and also available on the DMDD web site (https:// dmdd.org.uk). Embryos were obtained from 42 novel gene knockout lines, 31 classified as lethal and 11 as sub-viable (see Materials and methods; Table 1 ). This corresponds to an average of approximately 5 embryos for each mutant line, although in practice numbers ranged widely from 1 to 11 as a result of variable breeding efficiency and cost limitations inherent in a large scale screening programme (Supplementary Figure 1) . In total, 722,329 transverse section images obtained from the 220 embryos formed the basis for examining embryo structure and with the addition of digital resection of datasets in coronal and sagittal planes, scoring of phenotypes was based on examination of 1,634,134 images.
Incidence of structural abnormalities in homozygous mutant embryos Almost all embryos studied (209/220) showed structural abnormalities that could be identified by a phenotyping procedure previously established and refined from pilot studies 8 . The remaining 11 apparently normal embryos were obtained from 9 different lines, each of which yielded several other homozygous mutants bearing detectable morphological abnormalities. We have previously reported that the resolution afforded by 3D datasets obtained by HREM imaging allowed the detection of phenotypic abnormalities spanning in size range from individual nerves and blood vessels to gross organ and tissue malformations 8 . In the present study, a total of 398 different MP terms were employed to record a total of 2,939 detected embryo phenotypes (Dataset 1). Multiple abnormalities were scored in virtually all embryos. Most showed up to 10, but in some embryos as many as 50 phenotypes were recorded ( Figure 1A) . Whilst a few phenotypes (for example those affecting different parts of vertebrae or different parts of the vertebral column) were often scored repeatedly within affected embryos, their incidence was insufficient to have a significant impact on the overall distribution of phenotype numbers scored per embryo across the whole study. When analysed by individual mutant line, the incidence of detectable abnormalities is more broadly distributed, with more than half of the 42 lines showing between 10 and 49 different phenotypes ( Figure 1B ).
The disparity between phenotype incidence by embryo and phenotype incidence by line is striking and indicates that individual mutant embryos within each line show distinct, but partially overlapping spectra of phenotypes. This is graphically illustrated by data from the four lines shown in Figure 2 . The Atp11a allele exemplifies those mutant lines in which a significant proportion of phenotypes were detected across all the embryos scored. (Note that the data is summarised by high level MP ontology slim terms and individual embryos may still differ in the precise phenotypes actually scored. This may reflect differing degrees of severity amongst affected embryos or pleiotropic effects of mutations on individual organ systems). The Brd2 and Tcf712 alleles showed similar, but less pronounced, conservation of phenotype whilst the Celf4 allele is an example of those lines in which there was no detectable consistency to the phenotypes detected across the mutants analysed. Table 2 presents the frequency with which individual abnormalities were identified amongst the mutant embryos. Since some phenotypes (such as vertebral abnormalities) are often present multiply in affected embryos, the data is normalised for occurrence by embryo. Interestingly, the most common phenotype detected in this study was subcutaneous edema. This was evident from macroscopic observation of embryos at harvest and confirmed by subsequent HREM imaging (Figure 3 , panels A-C). In total, subcutaneous edema and edema in other body regions (scored with four distinct MP terms) affected one third (72/220) of the embryos and was observed in a little over half (24/42) of the mutant lines. Other prevalent phenotypes included defects affecting the vertebral arches, the ventricular septum of the heart, forebrain morphology and musculature of the developing eyes (Table 2 and Figure 3 ). Of particular note is the frequency with which mutant embryos showed abnormalities affecting the architecture or presence of the hypoglossal nerve (Figure 4, panels A and B) . Complete absence of the nerve occurred in 37 embryos, obtained from 12 different mutant lines, with some embryos from a similar number of lines showing abnormal topology or unusual thinness of the nerve (13 and 9 lines respectively). Overall, scored phenotypes affected all the major organ systems at E14.5 ( Figure 5A ) and multiple organs or tissues were frequently affected within individual embryos or collectively within a mutant line (Figure 2 and Supplementary Figure 2 and Supplementary Figure 3) . The complete listing of scored phenotypes is presented in Supplementary Table 1, organised according to the MP ontology slims adopted by the DMDD programme (see Table 4 and Table 5 ), with data ranked according to prevalence in mutant lines.
Prevalence of individual abnormalities
Individual phenotypes show highly variable penetrance
Perhaps the most striking finding of the DMDD study is the almost complete absence of any fully penetrant abnormalities. Amongst lines for which more than a single embryo was analysed, only three phenotypes showed 100% penetrance: abnormal perichondrial ossification (1 line; 10 mutant embryos), small nodose ganglion (1 line; 4 embryos) and small trigeminal ganglion (1 line, 3 embryos) . Furthermore, most defects showed surprisingly low penetrance. A penetrance greater than 75% within the line was only found for 7% of detected phenotypes. In contrast, over half (55%) of the scored abnormalities had a penetrance of 25% or less. (Table 3) . This is graphically illustrated in Figure 5A , in which the scored phenotypes are clustered according to high level MP ontology terms (broadly reflecting distinct organ systems, tissues or body regions) and the prevalence of each in the 42 mutant lines categorised by penetrance. All phenotypes show a broad range of penetrance, about half showing roughly symmetrical distribution of penetrance, with similar numbers of lines both above and below 50%. Interestingly, it is possible also to distinguish several phenotypes where penetrance is noticeably skewed. Abnormalities affecting the cardiovascular system, nervous system and skeleton all affected a relatively large number of lines and each showed a striking bias towards higher penetrance values. A second group of abnormalities encompassing liver/biliary, respiratory, renal and hearing systems showed a converse bias to penetrance values below 50% ( Figure 5A ). Figure 5B ). At this level of resolution, for example, cardiovascular defects are subdivided into two broad categories; those encompassing abnormalities in blood vessel morphology or topology ("abnormal blood vessel morphology" and most phenotypes within "abnormal cardiovascular development") and those affecting the heart and its great vessels ("abnormal heart morphology"). Viewed in this way, it is clear that detection of cardiovascular defects in all lines examined results from the presence of phenotypes in the vasculature. These range from relatively major defects such as absence of the ductus venosus, interrupted aortic arch or arterial stenosis, to more minor alterations in vascular topology in different regions of the embryo. Cardiac abnormalities nevertheless remain prevalent, affecting almost two thirds (27/42) of the mutant lines. These encompass malformations in all regions of the four-chambered heart and its great vessels, including both atrial and ventricular septal defects, atrioventricular septal defects, common arterial trunk, double outlet right ventricle, transposition of the great arteries, bicuspid aortic valve, common truncal valve and abnormally thin myocardium. After blood vessel and cardiac abnormalities, the third most prevalent group of phenotypes detected were those affecting brain morphology ( Figure 5B ), most commonly the forebrain ( Figure 6 and Supplementary Table 1 ).
In order to assess the relative significance of each phenotype in the context of variable penetrance, we re-examined their ranking distribution after weighting each phenotype according to its individual prevalence. This provides a plot of cumulative line Figure 2 . Individual embryos show overlapping but distinct spectra of phenotypes. The phenotypes annotated for individual embryos were normalised to remove duplicate ontology terms. The distinct terms for each homozygous mutant embryo from four lines were then mapped onto the broad set of ontology categories defined in the high level DMDD slim. The presence or absence of phenotype annotation within each of the high level categories was plotted for each embryo analysed. Figure 7 ). Whilst abnormalities in blood vessel morphology and structure of the heart remain amongst the most prevalent phenotypes, weighting by penetrance has a significant impact on the ranking of other phenotypes. Notably, the relative ranking of "abnormal brain morphology" and "abnormal somatic nervous system morphology" is increased, with both now lying in the five most prevalent abnormalities scored. This change is largely driven by the relatively high prevalence associated with abnormalities in forebrain morphology and hypoglossal nerve structure or presence, respectively.
Phenotyping embryos required new MP terms
Adoption of a formal, standardised ontology for scoring abnormalities provides an essential framework for analysing the data and facilitating structured search enquiries. However, during the course of the DMDD programme and its pilot study 8 , it became clear that additional terms were required in order to adequately describe abnormalities in embryo, as opposed to adult structures. A further outcome of the DMDD study has therefore been the creation of 142 new MP terms to accommodate the range of abnormalities we have observed ( Thinning of the lateral rectus muscle (lrm) (K). Absence of the lateral rectus muscle (lrm) (L). da, descending aorta; e, esophagus; g, adrenal gland; hb, hyoid bone; i, intestine; k, kidney; l, lung; la, left atrium; le, lens; li, liver; lrm, lateral rectus muscle; lv, left ventricle; lx, larynx; mrm, medial rectus muscle; oc, optic cup; on, optic nerve; ra, right atrium; rv, right ventricle; sc, spinal chord; t, tongue; tr, trachea; v, body of vertebra; va, arch of vertebra. Scale bars: 1 mm.
Figure 4. Other frequently observed abnormalities. A and B. Abnormal hyopglossal nerve in original HREM sections through the head of Prrc2b -/-(A) and a Polb -/-(B) embryo. Note the missing right hypoglossal nerve (arrowhead, inlay) in A and the thinning of both hypoglossal nerves (hn) in B. C-E. Abnormalities that also occur in controls. Persisting craniopharnygeal duct (arrowhead) as appearing in sagittal sections (C). Split tip of tail featured by volume models (D) and vesicles (arrowheads) in the lens (le) as appearing in an original HREM section (E).
http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary. org/obo/MP_0013945), and intramural bleeding in blood vessel wall (MP:0014020; http://www.ontobee.org/ontology/MP?iri=http:// purl.obolibrary.org/obo/MP_0014020) ( Figure 8 ).
Discussion
Since approximately one third of gene knockouts in the mouse prove to be embryonic or perinatal lethal [1] [2] [3] , further study of such lines offers a unique opportunity to better understand the genetic regulation of embryo development and identify genetic determinants of congenital abnormalities. The data accumulated during three years of the DMDD programme provide the first opportunity to study in detail the identity, range and prevalence of morphological abnormalities in such mutants and offer a window on the opportunities (and pitfalls) such systematic studies present.
The current analysis is restricted to a single developmental stage (E14.5) when most organ systems of the embryo have developed their definitive fetal appearance and the body plan is broadly similar to that of the adult mouse. Whilst this provides obvious practical advantages for a systematic, high throughput phenotyping programme, it is of course an arbitrary choice with respect to the time course of individual gene function and the consequences of gene ablation. Indeed, about 60% of the lethal lines entering the DMDD pipeline fail to provide homozygous mutant offspring by E14.5, with half of those causing lethality prior to E9.5 [see also 2].
The data here therefore comes from a subset of lethal lines. Furthermore, phenotypes observed at a single time point most likely combine more immediate consequences of individual gene loss with more distant or secondary consequences. Teasing out the role of regulative or compensatory changes from primary effects of gene loss is likely to be difficult. Despite these caveats, there are, nevertheless, several striking findings that emerge from detailed phenotype analysis. Our finding that some manifestation of edema (generally subcutaneous) is the most common phenotype could indicate an unappreciated complexity in the genetic controls regulating fluid balance or tissue integrity of vascular or lymphatic components. Edema may also represent a common outcome for a wide range of pathophysiological perturbations, as has been proposed for the association of non-immune hydrops fetalis with human fetal loss 10, 11 . The prevalence of cardiovascular defects is also consistent with the well established finding that cardiac abnormalities are the most common congenital defect in human newborns 12 . Some caution is necessary in considering the mouse data, since as we have shown, a significant proportion of cardiovascular phenotypes comprise apparently minor alterations in blood vessel topology, the impact of which on normal development remains unclear. However, in addition to these, the lines we have studied show a range of severe abnormalities in cardiac structure that are both relatively prevalent and mirror the range of congenital abnormalities seen in humans. Despite the largely random selection of genes studied in screens such as DMDD, their identification as embryonic lethal therefore provides a dramatic enrichment for potential cardiac developmental disease alleles. Phenotypes affecting neural tissue also prove to be relatively prevalent in mutant embryos. We are limited in the present analysis to identifying a subset of neural deficits readily identified from HREM imaging. This restricts identifiable phenotypes to relatively gross alterations in brain and neural tube morphology, or changes affecting major nerves. Amongst the latter, the frequency with which abnormalities affecting the hypoglossal nerve have been detected is perhaps not so surprising, since these (like abnormalities detected in the motoric portion of the trigeminal nerve) may compromise suckling and lead to perinatal lethality.
The multiplicity of phenotypes frequently detected in individual mutant embryos is not unexpected, given the nature of a single time point screening procedure combined with the likely pleiotropic effects of individual gene loss. However, the most striking and surprising finding to emerge from the DMDD phenotype data is that virtually all phenotypes are incompletely (and frequently poorly) penetrant, despite the use of the isogenic C57BL/6N mouse strain. Combined with the observation of overlapping but distinct spectra of phenotypes between individual embryos from a single line, these findings are challenging to understand, and at a minimum point towards unknown stochastic components affecting the etiology of -/-embryo from the DMDD pilot study 8 . Coronal section through a volume model. G-H. "Abnormal elbow joint morphology" Sagittal sections. Normal situation in a control (G). Fusion of humerus (h) und ulna material (u) in an Atp11a -/-embryo. aa, aortic arch; ah, adenohypophysis; bt, brachiocephalic trunk; da, descending aorta; dlaa, double lumen aortic arch; e, esophagus; h, humerus; l, lung; la, left atrium; lcc, left common carotid artery; le, lens; lsa, left subclavian artery; lx, larynx; mp, motoric part of trigeminal nerve; nc, nasal cavity; oc, optic cup; r, radius; ra, right atrium; rcc, right common carotid artery; rv, right ventricle; sc, spinal chord; tg, trigeminal ganglion; u, ulna; v, vertrebral body; III, 3rd ventricle; Scale bars 1 mm.
each phenotype or the compensatory responses they elicit 2 . They also demonstrate that efforts to identify linkage between mouse embryo phenotypes and human developmental disease are likely to require sophisticated bioinformatic analysis beyond the obvious issues raised by species differences in anatomy and physiology.
It is also worth noting the several practical lessons which have become evident through the course of DMDD studies and which may be of value for similar embryo phenotyping programmes. The most pressing of these is basing phenotype detection on comparison of each mutant embryo with an appropriately staged normal counterpart 13 . Embryos harvested at E14.5 vary markedly in their developmental progress and many tissues and organs are actively remodelled during this period. This is most obvious for the topology of the intestine, the position of the palatal shelves and the interventricular communication between left and right sides of the heart. Only with precise developmental staging is accurate phenotyping of these features possible (Geyer, Reissig, Rose, Wilson, Prin, Szumska, Ramirez-Solis, Tudor, White, Mohun and Weninger, unpublished report, ) .
Whilst the precise range and detail of phenotypes that can be scored will necessarily be dictated by the nature of the imaging modality and the method of phenotype identification (compare, for example, 14, 15 with the manual annotation used in the present study), a common challenge is the development of protocols to minimise occurrence or subsequent scoring of apparent abnormalities that are more likely artefacts of sample preparation or processing. These can range from the more obvious ruptures of the embryo skin or damaged external features during dissection, to tissue shrinkage or swelling (causing organ deformation) as a result of dehydration, fixation or embedding. In addition to such artefacts, our study has demonstrated that a number of apparent abnormalities are common to both homozygous mutant embryos and wild-type controls from the C57BL/6N mouse strain. These include splitting of the tail tip, persistence of the craniopharyngeal duct with associated fenestration of head bones and the presence of vesicles in the lens of the eye (Figure 4 , panels C-E). A systematic appraisal of such phenotypes is currently in preparation.
Finally, the power of phenotypic screens such as DMDD to inform our understanding of developmental disease rests heavily on the detail with which abnormalities are scored. However, the very complexity we have seen this generates makes it all the more urgent to distinguish phenotypes not just through the nature of the morphological abnormality, but through its capacity, individually or in concert with others, to compromise subsequent fetal survival.
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control embryos, would be essential to establish the link between mutations and described phenotypes. In the absence of this data, any reference to a causal link between phenotypes and mutation should be removed from the article.
Both targeted traps (tm1a) and null (tm1b and CRISPR induced deletions) alleles are employed in the study. Both the presence of a selection cassette and the unpredictability of efficiency of trapping cassette(s) could form the basis of at least some of the variability shown in this study. An evaluation of variability (particularly using slim terms) within each of these 2 groups of alleles would help to address this point.
Subviable lines show by definition a partially penetrant phenotype and contribute to a quarter of the mutant studied. An evaluation of variability (particularly using slim terms) within lethal and subviable as separate alleles groups would discriminate whether variability of morphology is particularly occurring among subviable lines.
Minor points:
Methods should detail information that permit the appraisal of materials used in the study, detailing the genetic background of stem cells and animals employed for germline transmission, and further breeding, including whether homozygotes were used to produce embryos to analyse subviable lines.
Methods should outline the steps taken to limit manual annotation variability (i.e. secondary calling or benchmarking between annotators).
All titles and text should precisely detail when lethal or both lethal and subviable mutations are presented.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
No competing interests were disclosed. Competing Interests: The Jackson Laboratory, Bar Harbor, ME, USA This manuscript describes the findings of the DMDD consortium, analyzing 42 lethal and subviable genes at E14.5 using high-resolution 3D imaging (HREM) coupled with detailed annotation of the specific phenotypes revealed. The level of granularity in the scoring of the phenotypes is a major strength of the paper, and reflects the deep and unique expertise of the team. This has facilitated the discovery of widespread variable penetrance in mutant embryos at a level of detail not previously described. Furthermore, the effort to organize the MP into a series of "slims" is quite useful for organizing the calls into easier to analyze groups, and such work will likely benefit other groups such as the IMPC.
The manuscript is clearly written and, importantly, goes to great lengths to ensure full access to all data. In 
The Deciphering the Mechanisms of Developmental Disorders (DMDD) programme aims to analyse 240 embryonic lethal mouse knockout lines over a five-year period to study genes essential for mouse embryonic development and survival. This paper provides the first report on results gathered thus far.
Wilson et al performed a detailed assessment of morphological abnormalities at stage E14.5 in 220 embryos from 42 novel mouse gene knockout lines. High Resolution Episcopic Microscopy was used to detect abnormalities at a scale from whole organs and tissues down to individual nerves and blood vessels. They report multiple abnormalities in virtually all of the embryos studied. They generated a wealth of information; in excess of 1.6 million images including more than 700,000 transverse sections to detail the incidence of structural abnormalities in 209 of the 220 embryos analysed. Eleven of the embryos from nine different lines were apparently normal.
To provide systematic phenotypic data Mammalian Phenotype (MP) ontology terms were used to classify abnormalities with high and intermediate levels. This allowed the authors to calculate a penetrance score for the terms in each of the mutant lines and to assign these to a quartile percentage group. Only 3 phenotypes were 100% penetrant and over half of the abnormalities had a penetrance score under 25%.
Approximately one third of mouse gene knockouts are lethal and 60% of lethal lines entering the DMDD programme fail to provide homozygous mutant offspring by E14.5 with half of those being lethal prior to E9.5. Thus, as the authors point out, the data presented are from a subset of lethal lines. However, the most striking aspect of this study is the variability in penetrance of virtually all of the phenotypes analysed.
Recent studies sequencing human exome DNA has identified a high frequency of loss of function mutations. A study by Lek et al 2016 examined more than 60,000 human exomes and reported predicted homozygous loss of function genotypes in 1775 genes. On average there are 35 homozygous gene deletions in each human. Thus the comment by Wilson et al in the present paper is particularly pertinent; relating these findings to human developmental disease will require further sophisticated analysis. It would appear that homozygous loss of function mutations are more common than previously realised and, furthermore, the consequences of loss of function mutations are much more variable than previously realised. It will not be trivial to unmask the causes of this variability. We are only just beginning to scratch the surface of understanding the consequences of loss of function mutations in both mice and humans.
I have only one minor suggestion. On p4 3 lines from the bottom, the sentence starting "The Brd2 and Tcf712 alleles showed a similar, but less pronounced, conservation of phenotype.." requires clarification. Do they mean similar to Atp11a, to each other, or to both?
